课题基金 / 基金详情

CLINICAL TRIAL: THALIDOMIDE IN THE TREATMENT OF WOMEN WITH CHRONIC PELVIC PAIN/E

CLINICAL TRIAL: THALIDOMIDE IN THE TREATMENT OF WOMEN WITH CHRONIC PELVIC PAIN/E
临床试验:沙利度胺治疗女性慢性盆腔疼痛/E
批准号:
7716783
负责人:
DENNIZ A ZOLNOUN
金额:
$0.19万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-02 至 2008-05-31

项目摘要

项目成果

DENNIZ A ZOLNOUN的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is an open label trial of Thalidomide for treatment of intractable chronic pelvic pain associated with endometriosis. Participant sare reproductive age women who have been intolerant or have failed all available conventional medical therapies, with hysterectomy as the only alternative treatment modality. We will enroll 17 women with intractable pain. Prior to enrollment, we will assess baseline quality of life and pain level. In addition to serial clincial evaluation (every 2-4 weeks), we will monitor any changes in TNF alpha and interleukin level during the active drug treatment. At the end of the three month therapy, the treatment will be terminated. Subjects will be reassessed at 6 months.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Refining Diagnostic Criteria of a Pain Disorder: Vulvar Vestibulitis Syndrome
Refining Diagnostic Criteria of a Pain Disorder: Vulvar Vestibulitis Syndrome
Refining Diagnostic Criteria of a Pain Disorder: Vulvar Vestibulitis Syndrome
THALIDOMIDE IN THE TREATMENT OF WOMEN WITH CHRONIC PELVIC PAIN/ENDOMETRIOSIS
海外基金